Type 1 tyrosinemia in Finland: a nationwide study | Orphanet Journal of Rare Diseases | Full Text

Type 1 tyrosinemia in Finland: a nationwide study | Orphanet Journal of Rare Diseases | Full Text

Type 1 tyrosinemia in Finland: a nationwide study

Introduction of nitisinone and newborn screening (NBS) have transformed the treatment of type 1 tyrosinemia, but the effects of these changes on the long-term outcomes remain obscure. Also, the predictors for ...

Authors:Linnea Äärelä, Pauliina Hiltunen, Tea Soini, Nina Vuorela, Heini Huhtala, Pasi I. Nevalainen, Markku Heikinheimo, Laura Kivelä and Kalle Kurppa

Citation:Orphanet Journal of Rare Diseases 2020 15:281

Content type:Research

 

Published on: 12 October 2020

• ViewFull Text
 
• ViewPDF